FLT3 and acute myeloid leukemia: Additionally, few studies included in the SLR reported the prevalence of the FLT3 mutations at different stages of disease progression, which is important to understand considering that FLT3 mutations can dynamically either be lost or arise at different stages of AML treatment and progression [3].